Quest Diagnostics (DGX) Depreciation and Depletion (2009 - 2026)

Quest Diagnostics has disclosed Depreciation and Depletion across 18 years of filings, most recently posting $110.0 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $110.0 million, up 8.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $425.0 million (up 11.84% YoY), and the FY2025 annual result was $416.0 million, up 13.66% from the prior year.
• Depreciation and Depletion came in at $110.0 million for Q1 2026 at Quest Diagnostics, up from $108.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $110.0 million in Q1 2026 to a low of $77.0 million in Q4 2022.
• The 5-year median for Depreciation and Depletion is $87.0 million (2024), against an average of $90.6 million.
• Across the five-year window, Depreciation and Depletion fell 3.75% in 2022 and increased 19.51% in 2024, its largest moves.
• Quest Diagnostics' Depreciation and Depletion stood at $77.0 million in 2022, then rose by 6.49% to $82.0 million in 2023, then grew by 19.51% to $98.0 million in 2024, then gained by 10.2% to $108.0 million in 2025, then rose by 1.85% to $110.0 million in 2026.
• The last three Depreciation and Depletion figures came in at $110.0 million (Q1 2026), $108.0 million (Q4 2025), and $103.0 million (Q3 2025), per Business Quant data.